ArticleScientific reports2025
Standardization of pharmacognostic characters and phytochemical study of Limeum obovatum vicary.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Limeum obovatum Vicary, a valuable member of the Aizoaceae family, is traditionally used for treating various ailments, yet its pharmacognostic and phytochemical attributes remain underexplored. This study establishes comprehensive standardization of L. obovatum through a multi-faceted approach, encompassing macroscopic and microscopic evaluations, physicochemical analyses, and advanced analytical techniques. Microscopic investigations, including transverse sectioning and scanning electron microscopy (SEM), revealed critical structural details, while fluorescence analysis highlighted unique chemical interactions under varying wavelengths. Phytochemical screening of ethanol, dichloromethane (DCM), and n-hexane extracts confirmed the presence of bioactive compounds such as alkaloids, phenols, flavonoids, and fixed oils, with quantitative estimations showing substantial phenolic and flavonoid content. Analytical profiling via thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC), and Fourier-transform infrared spectroscopy (FTIR) identified key compounds like quercetin and 2-Hexenal, emphasizing the plant's chemical diversity and therapeutic relevance. These findings not only provide pharmacognostic benchmarks for L. obovatum but also validate its traditional medicinal uses, paving the way for future pharmacological exploration and clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.